FdaApplication
ANDA 203323
Identifiers
- fda_app_no: ANDA203323
Properties
| Property | Value |
|---|---|
| applicant_name | SAGENT PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2016-05-12 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMIKACIN SULFATE | AMIKACIN SULFATE | 500MG(BASE)/ML(250MG/ML) | INJECTABLE;INJECTION |
| AMIKACIN SULFATE | AMIKACIN SULFATE | 1G(BASE)/4ML(250MG/ML) | INJECTABLE;INJECTION |
| AMIKACIN SULFATE | AMIKACIN SULFATE | EQ 250MG BASE/ML | INJECTABLE;INJECTION |
3 products